During the past decade, Mary Babb Randolph Cancer Center at West Virginia University Hospitals conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 46 clinical trials were completed, i.e. on average, 153.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 18 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mary Babb Randolph Cancer Center at West Virginia University Hospitals" #1 sponsor was "West Virginia University" with 21 trials, followed by "Children's Oncology Group" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "Eastern Cooperative Oncology Group" with 7 trials sponsored and "NSABP Foundation Inc" with 7 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mary Babb Randolph Cancer Center at West Virginia University Hospitals" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "West Virginia Clinical and Translational Science Institute" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Mary Babb Randolph Cancer Center at West Virginia University Hospitals" are "Breast Cancer" (13 trials), "Leukemia" (11 trials), "Lung Cancer" (8 trials), "Lymphoma" (7 trials) and "Glioblastoma Multiforme" (4 trials). Many other conditions were trialed in "Mary Babb Randolph Cancer Center at West Virginia University Hospitals" in a lesser frequency.

Most popular intervention types in "Mary Babb Randolph Cancer Center at West Virginia University Hospitals" are "Drug" (89 trials), "Biological" (27 trials), "Radiation" (16 trials), "Other" (14 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (14 trials), "vincristine sulfate" (11 trials), "filgrastim" (10 trials), "cytarabine" (9 trials) and "methotrexate" (9 trials). Other intervention names were less common.

The vast majority of trials in "Mary Babb Randolph Cancer Center at West Virginia University Hospitals" are 98 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Mary Babb Randolph Cancer Center at West Virginia University Hospitals". undefined are not yet recruiting, 10 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 66 completed trials in Mary Babb Randolph Cancer Center at West Virginia University Hospitals, 2 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Mary Babb Randolph Cancer Center at West Virginia University Hospitals, 9 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".